Evidence map›Paper›PMID 12093912›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

A structural basis for the activity of retro-Diels-Alder catalytic antibodies: evidence for a catalytic aromatic residue.

Marina Hugot, Nicolas Bensel, Monique Vogel, Martine T Reymond, Beda Stadler, Jean-Louis Reymond, Ulrich Baumann

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Catalytic mechanism andNature catalysis · 2021
    Article
  3. Structural contributions to multidrug recognition in the multidrug resistance (MDR) gene regulator, BmrR.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  4. Self-assembled gold nanocrystal micelles act as an excellent artificial nanozyme with ribonuclease activity.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2009
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marina HugotDepartment of Chemistry and Biochemistry, University of Berne, Freiestrasse 3, CH-3012 Berne, Switzerland.
Nicolas Bensel
Monique Vogel
Martine T Reymond
Beda Stadler
Jean-Louis Reymond
Ulrich Baumann

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nitroxyl synthase catalytic antibodies 10F11, 9D9, and 27C5 catalyze the release of nitroxyl from a bicyclic pro-drug by accelerating a retro-Diels-Alder reaction. The Fabs (antigen-binding fragments) of these three catalytic antibodies were cloned and sequenced. Fab 9D9 was crystallized in the apo-form and in complex with one transition state analogue of the reaction. Crystal structures of Fab 10F11 in complex with ligands mimicking substrate, transition state, and product have been determined at resolutions ranging from 1.8 to 2.3 A. Antibodies 9D9 and 10F11 show increased shape complementarity (as quantified by the program sc) to the hapten and to a modeled transition state as compared with substrate and product. The shape complementarity is mediated to a large extent by an aromatic residue (tyrosine or tryptophan) at the bottom of the hydrophobic active pocket, which undergoes pi-stacking interactions with the aromatic rings of the ligands. Another factor contributing to the different reactivity of the regioisomers probably arises because of hydrogen-bonding interactions between the nitroxyl bridge and the backbone amide of PheH101 and possibly a conserved water molecule.

Indexed as

Amino Acid SequenceAntibodies, CatalyticApoproteinsBase SequenceCatalytic DomainCloning, MolecularCrystallography, X-RayDNA PrimersHaptensImmunoglobulin Fab FragmentsModels, MolecularMolecular Sequence DataProtein ConformationSequence AlignmentSequence Homology, Amino AcidAntibodies, CatalyticApoproteinsDNA PrimersHaptensImmunoglobulin Fab Fragments

Identifiers

PMID12093912
PMCPMC124973

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.